Mecopen500 mcg

Mecopen 500 mcg is indicated in- Peripheral Neuropathies Diabetic Neuropathy Verteberal Syndrome Nerve Compression Syndrome Multiple sclerosis Amyotrophic lateral sclerosis Parkinson’s disease Alzheimer’s disease ... Read moreMecopen 500 mcg is indicated in- Peripheral Neuropathies Diabetic Neuropathy Verteberal Syndrome Nerve Compression Syndrome Multiple sclerosis Amyotrophic lateral sclerosis Parkinson’s disease Alzheimer’s disease Diabetic retinopathy Entrapment neuropathy Drug induced neuropathy Megaloblastic anemia due to Vitamin B12 deficiency

Drugs for Megaloblastic Anemia

Mecopen 500 mcg is the neurologically active form of vitamin B12 and occurs as a water-soluble vitamin in the body. It is a cofactor in the enzyme methionine synthase, which functions to transfer methyl groups for the regeneration of methionine from homocysteine. In anaemia, it increases erythrocyte production by promoting nucleic acid synthesis in the bone marrow and by promoting maturation and division of erythrocytes.

Tablet: The usual adult dosage is 500 mcg tablet three times daily. The dosage should be adjusted according to the age of patient and the severity of symptoms. Injection: Peripheral neuropathies: The usual adult dosage is  500 mcg Mecopen 500 mcg administered intramuscularly or intravenously three times a week.The dosage should be adjusted according to the age of patient and the severity of symptoms.  Megaloblastic anemia: The usual adult dosage is  500 mcg Mecopen 500 mcg administered intramuscularly or intravenously three times a week. After about two months of administration, dosage should be changed to one ampoule equivalent to 500 mcg of Mecopen 500 mcg every one to three months as maintenance therapy

Tablet: The usual adult dosage is 500 mcg tablet three times daily. The dosage should be adjusted according to the age of patient and the severity of symptoms. Injection: Peripheral neuropathies: The usual adult dosage is  500 mcg Mecopen 500 mcg administered intramuscularly or intravenously three times a week.The dosage should be adjusted according to the age of patient and the severity of symptoms.  Megaloblastic anemia: The usual adult dosage is  500 mcg Mecopen 500 mcg administered intramuscularly or intravenously three times a week. After about two months of administration, dosage should be changed to one ampoule equivalent to 500 mcg of Mecopen 500 mcg every one to three months as maintenance therapy

Decreased GI tract absorption with neomycin, aminosalicylic acid, H2-blockers and colchicine. Reduced serum concentrations with oral contraceptives. Reduced effects in anaemia with parenteral chloramphenicol.

Hypersensitivity to any component of this product.

Generally Mecopen 500 mcg is well tolerated. However, a few side effects like GI discomfort (including anorexia, nausea or diarrhea) & rash may be seen after administration of Mecopen 500 mcg.

Not recommended during pregnancy & lactation.

The medicine should not be used for months if there is no response at all after its use for a certain period of time.

Oral: Store at room temperature. Protect from moisture and light.Parenteral: Store at room temperature. Do not expose to direct light.

Use in children: Not recommended.

Drugs for Megaloblastic Anemia

Mecopen 500 mcg is the neurologically active form of vitamin B12 and occurs as a water-soluble vitamin in the body. It is a cofactor in the enzyme methionine synthase, which functions to transfer methyl groups for the regeneration of methionine from homocysteine. In anaemia, it increases erythrocyte production by promoting nucleic acid synthesis in the bone marrow and by promoting maturation and division of erythrocytes.

Not recommended during pregnancy & lactation.

Use in children: Not recommended.